Vimarsana
Biggest News Aggregation in the World

Page 7 - John Mafi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from John Mafi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In John Mafi Today - Breaking & Trending Today

Medicaid Expansion led to increased access to preventive care for low-income adults - Vimarsana News

Medicaid Expansion led to increased access to preventive care for low-income adults

People with low incomes who live in states that expanded Medicaid got more of the kind of health care that can keep them healthier in the long run, compared with similar people in non-expansion states, a new study finds.

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals - Vimarsana News

Interventions based on Choosing Wisely guidelines can reduce antibiotic overuse at safety-net hospitals

A statewide pay-for-performance intervention based on a set of guidelines called Choosing Wisely reduced rates of inappropriate antibiotic prescriptions to treat acute respiratory tract infections by an average of 18 percentage points, from 43% to 25%, across two large Los Angeles safety net hospitals.

Study: Alzheimer's Drug for Medicare Patients Could Cost U.S. at Least $2B Annually - Vimarsana News

Study: Alzheimer's Drug for Medicare Patients Could Cost U.S. at Least $2B Annually

Wide coverage of Alzheimer's drug Leqembi would raise future costs for Medicare by at least $2 billion a year, according to a study led by University of California researchers.

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 bln a year, study finds - Vimarsana News

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 bln a year, study finds

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University of California, Los Angeles (UCLA).

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year, study finds - Vimarsana News

Eisai, Biogen Alzheimer's drug Leqembi would cost US Medicare up to $5 billion a year, study finds

Wide coverage of Alzheimer's drug Leqembi would raise future costs for the U.S. Medicare health plan by $2 billion to $5 billion a year, according to a study led by researchers at the University... | May 11, 2023